- ►annals.org [PDF] TC Luke, EM Kilbane, JL Jackson, SL … - Annals of Internal Medicine, 2006 - Am Coll Physicians Background: Studies from the Spanish influenza era reported that transfusion of
influenza-convalescent human blood products re- duced mortality in patients with
influenza complicated by pneumo- nia. Treatments for H5N1 influenza are ... Cited by 44 - Related articles - BL Direct - All 5 versions
B Zhou, N Zhong, Y Guan - The New England journal of medicine, 2007 - nejm.highwire.org To the Editor: A previously healthy 31-year-old male van driver presented to a
local clinic in Shen- zhen, in southern China, on June 7, 2006, with a 4-day
history of a high fever (temperature, 39.9°C), chills, and a cough with ... Cited by 42 - Related articles - All 4 versions
BJ Hanson, A Boon, APC Lim, A Webb, EE … - Respiratory Research, 2006 - biomedcentral.com Highly pathogenic avian H5N1 influenza virus is a major public health concern.
Given the lack of effective vaccine and recent evidence of antiviral drug
resistance in some isolates, alternative strategies for containment of a ... Cited by 51 - Related articles - Cached - All 12 versions
J Lu, Z Guo, X Pan, G Wang, D Zhang, Y Li, B … - Respiratory research, 2006 - biomedcentral.com Avian influenza virus H5N1 has demonstrated considerable pandemic potential.
Currently, no effective vaccines for H5N1 infection are available, so passive
immunotherapy may be an alternative strategy. To investigate the possible ... Cited by 34 - Related articles - Cached - All 14 versions
CP Simmons, NL Bernasconi, AL Suguitan, K … - PLoS Med, 2007 - medicine.plosjournals.org Using Epstein-Barr virus we immortalized memory B cells from Vietnamese adults
who had recovered from infections with HPAI H5N1 viruses. Supernatants from B
cell lines were screened in a virus neutralization assay. B cell lines ... Cited by 55 - Related articles - Cached - All 16 versions
M Throsby, E van den Brink, M Jongeneelen, LLM … - PLoS One, 2008 - pubmedcentral.nih.gov The hemagglutinin (HA) glycoprotein is the principal target of protective
humoral immune responses to influenza virus infections but such antibody
responses only provide efficient protection against a narrow spectrum of HA ... Cited by 19 - Related articles - All 5 versions
- ►nih.gov AK Kashyap, J Steel, AF Oner, MA Dillon, RE … - Proceedings of the National Academy of Sciences, 2008 - National Acad Sciences The widespread incidence of H5N1 influenza viruses in bird populations poses
risks to human health. Although the virus has not yet adapted for facile
transmission between humans, it can cause severe disease and often death. ... Cited by 22 - Related articles - BL Direct - All 7 versions
- ►nih.gov J Wrammert, K Smith, J Miller, WA Langley, … - Nature, 2008 - nature.com Pre-existing neutralizing antibody provides the first line of defence against
pathogens in general. For influenza virus, annual vaccinations are given to
maintain protective levels of antibody against the currently circulating ... Cited by 36 - Related articles - BL Direct - All 10 versions
[CITATION] Ha do Q, Farrar J, de Jong MD, Lanzavecchia A, Subbarao K. Prophylactic and therapeutic …
S Khurana, AL Suguitan Jr, Y Rivera, CP … - PLoS Med, 2009 - medicine.plosjournals.org To address this need, we generated whole-genome–fragment phage display
libraries (GFPDL) expressing fragments of 15–350 amino acids covering all the
proteins of A/Vietnam/1203/2004 (H5N1). These GFPDL were used to analyze ... Cited by 5 - Related articles - Cached - All 10 versions
